These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26147748)

  • 1. Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain.
    Chan MC; Atasoylu O; Hodson E; Tumber A; Leung IK; Chowdhury R; Gómez-Pérez V; Demetriades M; Rydzik AM; Holt-Martyn J; Tian YM; Bishop T; Claridge TD; Kawamura A; Pugh CW; Ratcliffe PJ; Schofield CJ
    PLoS One; 2015; 10(7):e0132004. PubMed ID: 26147748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases.
    Chan MC; Ilott NE; Schödel J; Sims D; Tumber A; Lippl K; Mole DR; Pugh CW; Ratcliffe PJ; Ponting CP; Schofield CJ
    J Biol Chem; 2016 Sep; 291(39):20661-73. PubMed ID: 27502280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent inhibition of PHD2.
    Tcholakov I; Grimshaw CE; Shi L; Kiryanov A; Murphy ST; Larson CJ; Plonowski A; Ermolieff J
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28592559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer.
    Yu M; Lun J; Zhang H; Zhu L; Zhang G; Fang J
    Int J Biochem Cell Biol; 2021 Jun; 135():105982. PubMed ID: 33894356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl hydroxylases and therapeutics.
    Smith TG; Talbot NP
    Antioxid Redox Signal; 2010 Apr; 12(4):431-3. PubMed ID: 19761407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Activity Relationship and Crystallographic Studies on 4-Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors.
    Holt-Martyn JP; Chowdhury R; Tumber A; Yeh TL; Abboud MI; Lippl K; Lohans CT; Langley GW; Figg W; McDonough MA; Pugh CW; Ratcliffe PJ; Schofield CJ
    ChemMedChem; 2020 Feb; 15(3):270-273. PubMed ID: 31751494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stabilization of hypoxia inducible factor modulates differentiation status and inhibits the proliferation of mouse embryonic stem cells.
    Binó L; Kučera J; Štefková K; Švihálková Šindlerová L; Lánová M; Kudová J; Kubala L; Pacherník J
    Chem Biol Interact; 2016 Jan; 244():204-14. PubMed ID: 26723917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2.
    Richardson NL; O'Malley LJ; Weissberger D; Tumber A; Schofield CJ; Griffith R; Jones NM; Hunter L
    Bioorg Med Chem; 2021 May; 38():116115. PubMed ID: 33862469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Knockdown and Pharmacologic Inhibition of Hypoxia-Inducible Factor (HIF) Hydroxylases.
    Pickel C; Taylor CT; Scholz CC
    Methods Mol Biol; 2018; 1742():1-14. PubMed ID: 29330785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Things get broken: the hypoxia-inducible factor prolyl hydroxylases in ischemic heart disease.
    Schreiber T; Salhöfer L; Quinting T; Fandrey J
    Basic Res Cardiol; 2019 Mar; 114(3):16. PubMed ID: 30859331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,2,4-Triazolo-[1,5-a]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction.
    Ahmed S; Ayscough A; Barker GR; Canning HE; Davenport R; Downham R; Harrison D; Jenkins K; Kinsella N; Livermore DG; Wright S; Ivetac AD; Skene R; Wilkens SJ; Webster NA; Hendrick AG
    J Med Chem; 2017 Jul; 60(13):5663-5672. PubMed ID: 28594552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke.
    Reischl S; Li L; Walkinshaw G; Flippin LA; Marti HH; Kunze R
    PLoS One; 2014; 9(1):e84767. PubMed ID: 24409307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses.
    Rabinowitz MH
    J Med Chem; 2013 Dec; 56(23):9369-402. PubMed ID: 23977883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
    Chowdhury R; Candela-Lena JI; Chan MC; Greenald DJ; Yeoh KK; Tian YM; McDonough MA; Tumber A; Rose NR; Conejo-Garcia A; Demetriades M; Mathavan S; Kawamura A; Lee MK; van Eeden F; Pugh CW; Ratcliffe PJ; Schofield CJ
    ACS Chem Biol; 2013 Jul; 8(7):1488-96. PubMed ID: 23683440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases.
    Chowdhury R; Leung IK; Tian YM; Abboud MI; Ge W; Domene C; Cantrelle FX; Landrieu I; Hardy AP; Pugh CW; Ratcliffe PJ; Claridge TD; Schofield CJ
    Nat Commun; 2016 Aug; 7():12673. PubMed ID: 27561929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity.
    Jeong S; Park H; Hong S; Yum S; Kim W; Jung Y
    Eur J Pharmacol; 2015 Jan; 747():114-22. PubMed ID: 25483211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia.
    Ariazi JL; Duffy KJ; Adams DF; Fitch DM; Luo L; Pappalardi M; Biju M; DiFilippo EH; Shaw T; Wiggall K; Erickson-Miller C
    J Pharmacol Exp Ther; 2017 Dec; 363(3):336-347. PubMed ID: 28928122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the Substrate Selectivity of the Hypoxia-Inducible Factor Prolyl Hydroxylase 2 Catalytic Domain.
    Abboud MI; Chowdhury R; Leung IKH; Lippl K; Loenarz C; Claridge TDW; Schofield CJ
    Chembiochem; 2018 Nov; 19(21):2262-2267. PubMed ID: 30144273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
    Strowitzki MJ; Cummins EP; Taylor CT
    Cells; 2019 Apr; 8(5):. PubMed ID: 31035491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism.
    Koivunen P; Kietzmann T
    Trends Mol Med; 2018 Dec; 24(12):1021-1035. PubMed ID: 30391126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.